Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
370.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.109%)
Market Cap: £1.96b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Final Dividend and Enhanced Scrip Alternative

5 May 2022 07:00

RNS Number : 3330K
Hammerson PLC
05 May 2022
 

THIS ANNOUNCEMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

Hammerson plc (the "Company")

Final 2021 Dividend and Enhanced Scrip Dividend Alternative

5 May 2022

 

Further to the announcement of the Final 2021 Dividend and the Enhanced Scrip Dividend Alternative on Friday, 4 March 2022, the Board of Hammerson plc announces that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,716,406,719 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 194,637,920.

 

Therefore, applications have been submitted for 194,637,920 New Shares to be admitted to trading on the London Stock Exchange, the secondary listing segment of the Official List of the Irish Stock Exchange plc, trading as Euronext Dublin, and the Johannesburg Stock Exchange, which will bring the total number of issued 5 pence ordinary shares in the Company to 4,614,095,081.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange, Euronext Dublin and the Johannesburg Stock Exchange on Tuesday, 10 May 2022. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchanges.

 

Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated Wednesday, 23 March 2022 in connection with the Final 2021 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/dividend/scrip-dividend 

 

Enquiries

 

Josh Warren, Director of Strategy and Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVUPURUAUPPGWC
Date   Source Headline
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20254:45 pmRNSTotal Voting Rights
13th May 20257:00 amRNSTransaction in Own Shares
12th May 20259:20 amRNSHammerson increases its interest in Brent Cross
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20254:30 pmRNSTotal Voting Rights
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 202512:30 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20252:00 pmRNSTotal Voting Rights
22nd Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20254:40 pmRNSEMTN Programme: publication of Base Prospectus
15th Apr 20253:30 pmRNSTotal Voting Rights
15th Apr 20259:30 amRNSDividend Currency Conversion Announcement
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:01 amRNSTotal Voting Rights
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20253:30 pmRNSDirector/PDMR Shareholding
8th Apr 202512:30 pmRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20253:00 pmRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20252:30 pmRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20251:30 pmRNSDirector Declaration
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20251:00 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20253:45 pmRNSTotal Voting Rights
25th Mar 20253:00 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.